Zobrazeno 1 - 10
of 41
pro vyhledávání: '"KM Wyvill"'
Autor:
RW Humphrey, TR O'Brien, FM Newcomb, H Nishihara, KM Wyvill, GA Ramos, MW Saville, JJ Goedert, SE Straus, R Yarchoan
Publikováno v:
Blood. 88(1)
Herpesvirus-like DNA sequences (KSHV/HHV-8) have recently been described in AIDS-associated Kaposi's sarcoma (KS) lesions. Many questions remain regarding the role of this virus in KS and the therapeutic implications of this finding. In the current s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49c10689dbada0dc131558aa383eb0db
https://pubmed.ncbi.nlm.nih.gov/8704186
https://pubmed.ncbi.nlm.nih.gov/8704186
Immunophenotypic analysis in participants with Kaposi sarcoma following pomalidomide administration.
Autor:
Lurain K; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Polizzotto MN; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Krug LT; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Shoemaker G; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Singh A; HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, USA., Jensen SMR; HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, USA., Wyvill KM; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Ramaswami R; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Uldrick TS; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Yarchoan R; HIV & AIDS Malignancy Branch, Center for Cancer Research (CCR), NCI., Sereti I; HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, USA.
Publikováno v:
AIDS (London, England) [AIDS] 2023 Sep 01; Vol. 37 (11), pp. 1693-1703. Date of Electronic Publication: 2023 Jun 19.
Autor:
Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Polizzotto MN; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Wyvill KM; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Widell A; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., George J; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Goncalves P; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Steinberg SM; Biostatistics and Data Management Section, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, NCI, NIH, Bethesda, Maryland., Uldrick TS; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland., Yarchoan R; HIV and AIDS Malignancy Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Mar 01; Vol. 28 (5), pp. 840-850.
Autor:
Ramaswami R; HIV & AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, Maryland. ramya.ramaswami@nih.gov., Uldrick TS; HIV & AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Polizzotto MN; HIV & AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Wyvill KM; HIV & AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Goncalves P; HIV & AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Widell A; HIV & AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Lurain K; HIV & AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Steinberg SM; Biostatistics and Data Management Section, Center for Cancer Research, NCI, Bethesda, Maryland., Figg WD; Molecular Pharmacology Branch, Center for Cancer Research, NCI, Bethesda, Maryland., Tosato G; Laboratory of Cellular Oncology, Center for Cancer Research, NCI, Bethesda, Maryland., Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos-Biomedical, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Yarchoan R; HIV & AIDS Malignancy Branch, Center for Cancer Research, NCI, Bethesda, Maryland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Jul 15; Vol. 25 (14), pp. 4238-4247. Date of Electronic Publication: 2019 Apr 12.
Autor:
Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Polizzotto MN; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Aleman K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Bhutani M; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Wyvill KM; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gonçalves PH; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Marshall VA; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Miley W; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Steinberg SM; Biostatistics and Data Management Section., Little RF; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Wilson W; Lymphoid Malignancies Branch, and., Filie AC; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and., Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and., Jaffe ES; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and., Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD., Yarchoan R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Uldrick TS; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Fred Hutchinson Cancer Research Center, Seattle, WA.
Publikováno v:
Blood [Blood] 2019 Apr 18; Vol. 133 (16), pp. 1753-1761. Date of Electronic Publication: 2019 Feb 19.
Autor:
Pastrana DV; Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, USA pastrand@mail.nih.gov., Peretti A; Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, USA., Welch NL; Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, USA., Borgogna C; Novara Medical School, Novara, Italy., Olivero C; Novara Medical School, Novara, Italy., Badolato R; University of Brescia, Brescia, Italy., Notarangelo LD; University of Brescia, Brescia, Italy., Gariglio M; Novara Medical School, Novara, Italy., FitzGerald PC; NCI Genome Analysis Unit, NCI, Bethesda, Maryland, USA., McIntosh CE; NCI Genome Analysis Unit, NCI, Bethesda, Maryland, USA., Reeves J; Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, USA., Starrett GJ; Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, USA., Bliskovsky V; Cancer Genetics Branch, NCI, Bethesda, Maryland, USA., Velez D; Molecular Signaling Section, Laboratory of Molecular Immunology, NIAID, Bethesda, Maryland, USA., Brownell I; National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Yarchoan R; HIV and AIDS Malignancy Branch, NCI, Bethesda, Maryland, USA., Wyvill KM; HIV and AIDS Malignancy Branch, NCI, Bethesda, Maryland, USA., Uldrick TS; HIV and AIDS Malignancy Branch, NCI, Bethesda, Maryland, USA., Maldarelli F; Host Virus Interaction Branch, NCI, Bethesda, Maryland, USA., Lisco A; Laboratory of Immunoregulation, NIAID, Bethesda, Maryland, USA., Sereti I; Laboratory of Immunoregulation, NIAID, Bethesda, Maryland, USA., Gonzalez CM; Department of Urology, Case Western Reserve University, Cleveland, Ohio, USA.; Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA., Androphy EJ; Stark Neurosciences Research Institute, Indiana University, Indianapolis, Indiana, USA., McBride AA; DNA Tumor Virus Section, NIAID, Bethesda, Maryland, USA., Van Doorslaer K; School of Animal and Comparative Biomedical Sciences, Department of Immunobiology, Cancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, Arizona, USA.; School of Animal and Comparative Biomedical Sciences, Department of Immunobiology, Genetics Graduate Interdisciplinary Program, University of Arizona, Tucson, Arizona, USA.; Bio5 Institute, University of Arizona, Tucson, Arizona, USA.; University of Arizona Cancer Center, University of Arizona, Tucson, Arizona, USA., Garcia F; Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA., Dvoretzky I; Yale University, New Haven, Connecticut, USA., Liu JS; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Han J; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Murphy PM; Molecular Signaling Section, Laboratory of Molecular Immunology, NIAID, Bethesda, Maryland, USA., McDermott DH; Molecular Signaling Section, Laboratory of Molecular Immunology, NIAID, Bethesda, Maryland, USA., Buck CB; Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, USA.
Publikováno v:
MSphere [mSphere] 2018 Dec 12; Vol. 3 (6). Date of Electronic Publication: 2018 Dec 12.
Autor:
Marshall VA; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Labo N; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Sztuba-Solinska J; Basic Research Laboratory, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Department of Biological Sciences, Auburn University, Auburn, AL, USA., Cornejo Castro EM; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Aleman K; HIV and AIDS Malignancy Branch, National Institutes of Health, Bethesda, MD, USA., Wyvill KM; HIV and AIDS Malignancy Branch, National Institutes of Health, Bethesda, MD, USA., McNamara L; Department of Internal Medicine, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa., Le Grice SFJ; Basic Research Laboratory, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Yarchoan R; HIV and AIDS Malignancy Branch, National Institutes of Health, Bethesda, MD, USA., Uldrick TS; HIV and AIDS Malignancy Branch, National Institutes of Health, Bethesda, MD, USA., MacPhail P; Clinical HIV Research Unit, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa., Polizzotto MN; HIV and AIDS Malignancy Branch, National Institutes of Health, Bethesda, MD, USA., Whitby D; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Publikováno v:
Oncotarget [Oncotarget] 2018 Nov 09; Vol. 9 (88), pp. 35856-35869. Date of Electronic Publication: 2018 Nov 09 (Print Publication: 2018).
Autor:
Roshan R; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Labo N; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Trivett M; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Miley W; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Marshall V; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Coren L; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Cornejo Castro EM; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Perez H; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Holdridge B; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Davis E; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Matus-Nicodemos R; Vaccine Research Center, National Institute of Allergy and Infectious Disease, Bethesda, MD, USA., Ayala VI; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Sowder R 2nd; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Wyvill KM; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Aleman K; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Fennessey C; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Lifson J; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Polizzotto MN; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Douek D; Vaccine Research Center, National Institute of Allergy and Infectious Disease, Bethesda, MD, USA., Keele B; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Uldrick TS; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD, USA., Ohlen C; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Ott D; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Whitby D; AIDS and Cancer Virus Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 Nov 25; Vol. 8 (65), pp. 109402-109416. Date of Electronic Publication: 2017 Nov 25 (Print Publication: 2017).
Autor:
Sanchez-Martin D; Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, USA., Uldrick TS; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Kwak H; Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, USA., Ohnuki H; Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, USA., Polizzotto MN; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Annunziata CM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Raffeld M; Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA., Wyvill KM; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Aleman K; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Wang V; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Marshall VA; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Whitby D; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Tosato G; Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2017 Sep 01; Vol. 109 (9).
Autor:
Uldrick TS; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA uldrickts@mail.nih.gov., Gonçalves PH; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Wyvill KM; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Peer CJ; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Bernstein W; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Aleman K; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Polizzotto MN; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Venzon D; Biostatistics and Data Management Section at the Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Steinberg SM; Biostatistics and Data Management Section at the Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Marshall V; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Whitby D; Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Little RF; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA., Wright JJ; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA., Rudek MA; Analytical Pharmacology Core, Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Figg WD; Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA., Yarchoan R; HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, Maryland, USA.
Publikováno v:
The oncologist [Oncologist] 2017 May; Vol. 22 (5), pp. 505-e49. Date of Electronic Publication: 2017 Mar 24.